E47, also known as TCF3 (Transcription factor 3), belongs to the E-protein family of helix-loop-helix transcription factors. These transcription factors play pivotal roles in various cellular processes, especially in the regulation of gene expression during early development, differentiation, and cell fate decisions. The E47 protein can form homodimers or heterodimers with other proteins, allowing it to bind DNA at specific E-box sequences and regulate the transcription of target genes. Given its fundamental role in transcriptional regulation, the modulation of E47 activity can profoundly affect cellular outcomes.
E47 Inhibitors refer to a class of molecules designed to interfere with the activity of E47, typically by preventing its binding to DNA or its dimerization with other proteins. In essence, these inhibitors aim to prevent E47 from effectively recognizing or binding to its target sequences in the genome, thereby hindering its capacity to modulate gene expression. Some of these inhibitors might target the protein's DNA-binding domain, disrupting its interaction with E-box sequences. Others could interfere with the dimerization process, an essential step for E47's transcriptional activity. In addition to small molecules, peptide-based inhibitors that mimic the helix-loop-helix domain or other essential regions of E47 have also been of interest, as they can interfere with protein-protein interactions critical for E47 function. Overall, these inhibitors provide valuable tools for researchers aiming to understand the intricate roles of E47 in cellular processes and its interplay with other transcriptional regulators.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a BET bromodomain inhibitor that disrupts the interaction between E47 and bromodomain-containing proteins. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
AZD5363 is an inhibitor of AKT kinase, which can indirectly affect E47 activity by modulating signaling pathways. | ||||||
ABT-199 | 1257044-40-8 | sc-472284 sc-472284A sc-472284B sc-472284C sc-472284D | 1 mg 5 mg 10 mg 100 mg 3 g | $118.00 $337.00 $520.00 $832.00 $1632.00 | 10 | |
ABT-199 inhibits BCL-2, a protein that can interact with E47, leading to apoptotic cell death. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
ATRA induces E47 expression in certain cell types, promoting differentiation and inhibiting proliferation. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 inhibits TGF-β receptor signaling, which can modulate E47 expression and function in certain contexts. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a proteasome inhibitor that can stabilize E47 protein levels by preventing its degradation. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Nutlin-3 disrupts the interaction between E3 ligase MDM2 and p53, leading to p53-mediated effects on E47 activity. | ||||||
THZ1 | 1604810-83-4 | sc-507542 | 1 mg | $95.00 | ||
THZ1 is a CDK7 inhibitor that can indirectly impact E47 through regulation of transcriptional processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which can influence E47 activity through the mTOR signaling pathway. | ||||||
ITF2357 | 732302-99-7 | sc-364513 sc-364513A | 5 mg 50 mg | $340.00 $1950.00 | ||
Givinostat is a histone deacetylase (HDAC) inhibitor that can affect chromatin remodeling and E47-mediated gene expression. | ||||||